NORTHROP GRUMMAN CORP 2026 Q1
Earnings Overview & AI Insights

Earnings Performance

Summary of Financial Performance: Northrop Grumman delivered a strong Q1 2026, with sales of $9.9B, up 4% year over year (5% organic). Segment operating income rose to over $1B, with margins improving to 10.8%. Diluted EPS was $6.14, and backlog remained very strong at $96B. Awards totaled $9.8B in the quarter. Cash flow was a use of about $1.8B in Q1, consistent with seasonal patterns, and the company ended with over $2B of cash. Management reaffirmed full-year 2026 guidance: sales of $43.5B–$44.0B, low-to-mid 11% segment operating margin, and free cash flow of $3.1B–$3.5B. CapEx guidance increased to $1.85B, driven by an additional $200M investment for B-21 capacity.

Company Outlook & Strategy: Management was constructive and confident, emphasizing profitable growth, backlog strength, and long-term value creation. The company continues to invest in capacity, facilities, and production scale to meet rising demand and accelerate key programs. Strategic priorities include speeding up Sentinel, increasing B-21 production, expanding solid rocket motor capacity, and supporting missile defense and triad modernization. Management highlighted that B-21 production has already been increased by 25% and that the company expects long-term revenue and economics to improve as new capacity comes online.

Key Industry Trends: The call emphasized a strong global defense spending environment driven by geopolitical tensions and modernization needs. Management cited roughly 40% growth in global military spending over the past decade and pointed to a proposed FY2027 U.S. defense budget of $1.5T, or about 5% of GDP if enacted. Areas of heightened demand include the Middle East, missile defense, counter-UAS, hypersonic defense, and triad modernization. The company also noted bipartisan support for higher defense spending and growing government emphasis on structured, long-term production frameworks.

Operational Highlights: Northrop noted major operational expansion, including more than 20 new facilities and over 2M square feet of added manufacturing space in the last two years. Tactical solid rocket motor capacity has doubled, with more expansion planned through 2027. Sentinel is ramping, with double-digit Q1 growth and Milestone B expected later in 2026. B-21 testing is progressing, including aerial refueling trials, with first delivery to Ellsworth planned for 2027. The company also secured a $1.3B cumulative award for Glide Phase Interceptor development after quarter-end. Artemis II also highlighted Northrop’s space propulsion capability.

Challenges & Risks: Key headwinds included lower volume on F/A-18, prior-year NGI contract closeout benefits, and an unfavorable $71M adjustment on the GEM 63XL program in Space. Management also acknowledged that B-21-related capital spending will pressure near-term cash flow, with major CapEx concentrated in 2027–2029. Broader execution risk remains tied to scaling production efficiently, program timing, and continued alignment with customer funding and approvals.

Key Analyst Questions & Responses: Analysts focused heavily on B-21 production timing, CapEx phasing, and protection against potential program curtailment. Management said about $200M of B-21 CapEx is expected in 2026, with most spending occurring in 2027–2029, and revenue following facility completion. Kathy Warden said the contract includes a committed quantity and that the Air Force is considering increasing the program of record, supported by strong administration backing for triad modernization. A question on Sentinel timing confirmed Milestone B later in 2026, first flight in 2027, and IOC in the early 2030s, with acceleration efforts underway in partnership with the Air Force.